Breaks Categories: News

WednesdayOct 28, 2020 11:50 am

NetworkNewsBreaks – Investor Summit Group Announces Virtual Fall Summit Event to Bring Together High-Quality Investors, Companies

Investor Summit (“ISG”), one of the largest independent investor conferences on the East Coast, has announced details about its annual fall event. ISG’s upcoming Virtual Fall Summit is slated for Nov. 16–18, 2020. This premier event, recognized throughout the industry for bringing together an exclusive network of high-quality investors and promising companies, will continue that legacy by hosting 75 companies, carefully curated and representing a variety of industries, including healthcare, technology, consumer, financial, energy, cannabis and blockchain. Keynote presentations will discuss each of these relevant topics as well. The summit also features 30 expert speakers and buy-side panels and self-side…

Continue Reading

WednesdayOct 28, 2020 11:23 am

NetworkNewsBreaks – NetworkNewsWire, Benzinga Collaborate to Showcase Best and Most Innovative Companies in Global Fintech

Widely recognized as the fintech industry’s top competition, the Benzinga Global Fintech Awards will be returning on Nov. 10, in a sixth-annual installment, for a day of networking, deal-making and recognition of incredible achievements. This year’s event, set to be hosted in an entirely virtual format, will bring together more than 450 disruptive fintech companies, investors from around the world and hundreds of attendees to celebrate a truly extraordinary year for global finance. As part of expanding visibility, NetworkNewsWire (“NNW”) will serve as the event’s official newswire and provide up-to-the-minute news and information about the Benzinga Global Fintech Awards via…

Continue Reading

WednesdayOct 28, 2020 11:13 am

NetworkNewsBreaks – ISW Holdings Inc. (ISWH) Announces Breakout Revenues, Aggressive Moves to Remove Dilution Risk, Plans to Uplist

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced a preliminary qualitative performance update for the three months ended Sept. 30, 2020. In addition, ISWH provided an update on its recent moves to significantly reduce debt and authorized shares, as well as its plans to uplist to the OTCQB exchange tier. While precise data is not yet available in a form that may be publicly announced, ISW Holdings disclosed another breakout quarter, with new record high revenues for the three months ended Sept. 30, 2020. “Our Home Healthcare and Telehealth segment continues to expand significantly, and we…

Continue Reading

WednesdayOct 28, 2020 10:44 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Present at Zooming with LD

SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it will present virtually at Zooming with LD. SRAX’s presentation is slated to take place at 11:00 a.m. ET on Friday, Oct. 30, 2020. Chris Miglino, chief executive officer of SRAX, will be giving the presentation and answering questions from investors. Investors and other interested parties may register at https://nnw.fm/TfMrU to access the live, virtual presentation. To view the full press release, visit https://nnw.fm/sWu5t About SRAX Inc. SRAX is a financial technology company that unlocks…

Continue Reading

WednesdayOct 28, 2020 10:23 am

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million in the same quarter last year; third-quarter gross profit increased 47% to $1.9 million, compared to gross profit of $1.3 million in the same quarter last year; and third-quarter net income reached $0.14 million compared to net income in the same quarter last year. Business highlights for the quarter included the addition of 144 new independent pharmacies; the unveiling of Bonum+, a B2B platform that…

Continue Reading

WednesdayOct 28, 2020 9:53 am

NetworkNewsBreaks – Amesite Inc. (NASDAQ: AMST) Featured on Nasdaq’s ‘Trade Talks’ Following IPO

Amesite’s (NASDAQ: AMST) CEO and Founder Dr. Ann Marie Sastry appeared on “Trade Talks” following the company’s IPO on Nasdaq. Amesite is an artificial intelligence software company providing online learning ecosystems for business, higher education and K-12. Dr. Sastry joined host Jill Malandrino for the segment titled “#TradeTalks: Celebrating Amesite's Recent IPO and Exploring Education Tech Trends.” The discussion covered the timing of AMST going public during the current pandemic and how it helps fulfill the company’s mission of making high-quality virtual education accessible. The interview aired on Monday, Oct. 5, and can be accessed via the following link: https://nnw.fm/hBtQS.…

Continue Reading

TuesdayOct 27, 2020 2:22 pm

NetworkNewsBreaks – Knightscope Inc. Appoints Experienced Financial Exec as CFO, Announces Online Opportunity to Invest

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, today announced the appointment of Mallorie Burak as the company’s executive vice president and chief financial officer. Burak brings to the company over 25 years of expertise across a broad spectrum of industries ranging from early stage start-ups to multi-national public corporations. Over the span of her career, she has negotiated and managed over $500 million of successful financing and M&A deals and has focused the last 13 years on turnarounds and special situations for both public and venture-backed companies. In addition,…

Continue Reading

TuesdayOct 27, 2020 1:52 pm

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Positive Results in Ongoing Phase 2 Combination Therapy Trial with MS1819

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, recently announced positive results from the first five patients in its Phase 2 combination therapy trial of MS1819 for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). In the primary efficacy analysis, patients receiving MS1819 in combination with PERT therapy achieved a clinically meaningful improvement in the coefficient of fat absorption (“CFA”) at each of the three dose levels. No adverse safety events were reported and, additionally, patients showed improvements in the key secondary endpoints, including body weight, stool consistency and reductions in the number of bowel…

Continue Reading

TuesdayOct 27, 2020 1:09 pm

NetworkNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Featured on Critical Minerals Segment of ‘Mornings with Maria’

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an innovative technology and lithium project development company, today announced that its CEO Robert Mintak was a featured guest on Fox Business Network’s “Mornings with Maria” with anchor Maria Bartiromo. During the segment, which aired on Monday October 26, 2020, the two discussed the need for the lithium industry to adjust the critical minerals supply chain from China to the United States. Mintak summarized the progress being made at Standard Lithium’s Arkansas project. He highlighted the fact that currently the only lithium extraction that is actively underway in the U.S. is at…

Continue Reading

TuesdayOct 27, 2020 12:31 pm

NetworkNewsBreaks – Predictive Oncology (NASDAQ: POAI) CEO Provides Company Updates on Exclusive NNW Audio Interview

Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz was featured in a recent NetworkNewsWire (“NNW”) audio interview. During the interview, Schwartz provided updates on the company’s subsidiaries, noted recent company milestones and outlined near-term goals. POAI, a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has four wholly owned subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Schwartz focused the discussion on these companies, offering brief insight into the operations of Skyline Medical and noting that the purpose of TumorGenesis was to develop a lab media to replace rats and mice in the scientific industries…

Continue Reading